Chinese firm warned for making OTC eye drops without microbiological safeguards
Regulatory NewsJoanne S. EglovitchAudit/FDA InspectionChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy